NDA/BLA filedoutcome: unknownconf 0.99

beremagene geperpavec — NDA/BLA filed

$KRYS · Krystal Biotech, Inc. · Dystrophic Epidermolysis Bullosa

Event date

August 18, 2022

1388 days ago

Sponsor runway

cash-flow +

$501.3M liquid

Evidence

“On August 18, 2022, the FDA accepted the Company's BLA for B-VEC for the treatment of patients with dystrophic epidermolysis bullosa.”

Source: 8-K filed 2022-08-18View on EDGAR ↗0001711279-22-000052

Comparable historical nda/bla fileds· last 5 years · same event type

Ticker	Drug	Date	Outcome
$AXSM	—	2025-12-31	unknown
$RCKT	kresladi	2025-10-14	unknown
$ALDX	reproxalap	2025-07-17	unknown
$ETON	et-600	2025-07-08	unknown
$BCRX	orladeyo (berotralstat)	2025-05-14	unknown
$CORT	relacorilant	2025-03-03	unknown
$ALDX	reproxalap	2024-11-01	unknown
$AXSM	axs-07	2024-09-04	unknown
$RCKT	kresladi	2023-10-02	unknown
$GERN	imetelstat	2023-08-21	unknown

Recent insider activity· ±90 days

7 insiders · 0 buys · 16 sells

Sell

2022-11-08

Krishnan Suma

President, R&D

823 @ $80.04$66K

Sell

2022-11-08

Krishnan Suma

President, R&D

966 @ $80.05$77K

Sell

2022-11-08

Krishnan Krish S

President and CEO

966 @ $80.05$77K

Sell

2022-11-08

Krishnan Krish S

President and CEO

823 @ $80.04$66K

Sell

2022-08-05

Krishnan Suma

President, R&D

8,992 @ $80.22$721K

Sell

2022-08-05

Krishnan Suma

President, R&D

13,432 @ $81.62$1.10M

Sell

2022-08-05

Krishnan Suma

President, R&D

2,576 @ $82.20$212K

Sell

2022-08-05

Krishnan Suma

President, R&D

9,088 @ $80.24$729K

Sell

2022-08-05

Krishnan Suma

President, R&D

13,058 @ $81.61$1.07M

Sell

2022-08-05

Krishnan Suma

President, R&D

2,854 @ $82.19$235K

Sell

2022-08-05

Krishnan Krish S

President and CEO

9,088 @ $80.24$729K

Sell

2022-08-05

Krishnan Krish S

President and CEO

13,058 @ $81.61$1.07M

Sell

2022-08-05

Krishnan Krish S

President and CEO

2,854 @ $82.19$235K

Sell

2022-08-05

Krishnan Krish S

President and CEO

8,992 @ $80.22$721K

Sell

2022-08-05

Krishnan Krish S

President and CEO

13,432 @ $81.62$1.10M

Sell

2022-08-05

Krishnan Krish S

President and CEO

2,576 @ $82.20$212K

Grant

2022-06-30

Sutherland Everett Rand

Director

6,800 @ ——

Grant

2022-06-30

ROSSI DINO A

Director

6,800 @ ——

Grant

2022-06-30

JANNEY DANIEL

Director

6,800 @ ——

Grant

2022-06-30

Mason Christopher

Director

6,800 @ ——

Grant

2022-06-30

Gangolli Julian S

Director

6,800 @ ——

Date	Insider	Action	Shares	Price	Value
2022-11-08	Krishnan SumaPresident, R&D	Sell	823	$80.04	$66K
2022-11-08	Krishnan SumaPresident, R&D	Sell	966	$80.05	$77K
2022-11-08	Krishnan Krish SPresident and CEO	Sell	966	$80.05	$77K
2022-11-08	Krishnan Krish SPresident and CEO	Sell	823	$80.04	$66K
2022-08-05	Krishnan SumaPresident, R&D	Sell	8,992	$80.22	$721K
2022-08-05	Krishnan SumaPresident, R&D	Sell	13,432	$81.62	$1.10M
2022-08-05	Krishnan SumaPresident, R&D	Sell	2,576	$82.20	$212K
2022-08-05	Krishnan SumaPresident, R&D	Sell	9,088	$80.24	$729K
2022-08-05	Krishnan SumaPresident, R&D	Sell	13,058	$81.61	$1.07M
2022-08-05	Krishnan SumaPresident, R&D	Sell	2,854	$82.19	$235K
2022-08-05	Krishnan Krish SPresident and CEO	Sell	9,088	$80.24	$729K
2022-08-05	Krishnan Krish SPresident and CEO	Sell	13,058	$81.61	$1.07M
2022-08-05	Krishnan Krish SPresident and CEO	Sell	2,854	$82.19	$235K
2022-08-05	Krishnan Krish SPresident and CEO	Sell	8,992	$80.22	$721K
2022-08-05	Krishnan Krish SPresident and CEO	Sell	13,432	$81.62	$1.10M
2022-08-05	Krishnan Krish SPresident and CEO	Sell	2,576	$82.20	$212K
2022-06-30	Sutherland Everett RandDirector	Grant	6,800	—	—
2022-06-30	ROSSI DINO ADirector	Grant	6,800	—	—
2022-06-30	JANNEY DANIELDirector	Grant	6,800	—	—
2022-06-30	Mason ChristopherDirector	Grant	6,800	—	—
2022-06-30	Gangolli Julian SDirector	Grant	6,800	—	—

← All catalysts for $KRYS